NEW YORK (GenomeWeb) – GenMark Diagnostics said in a regulatory document today that it borrowed $10 million against a $40 million debt facility. 

The $10 million was borrowed under an initial term loan pursuant to a debt facility created in January and led by GE Capital's Healthcare Financial Services business. The credit facility comprises a multi-tranched $35 million venture loan facility and a $5 million asset-based revolving credit facility.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.